-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P4zzcT1Ybktn0rHMNHUCUasNNtRqFoBisB6WLuawJLyOePNIFC6eAJn8khN1F+aw N4AFfFTtGfozb+vCFpkcbg== 0001209191-05-014022.txt : 20050307 0001209191-05-014022.hdr.sgml : 20050307 20050307113218 ACCESSION NUMBER: 0001209191-05-014022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050303 FILED AS OF DATE: 20050307 DATE AS OF CHANGE: 20050307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOSE TECHNOLOGIES INC CENTRAL INDEX KEY: 0000877902 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133549286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WITMER RD CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 2154415890 MAIL ADDRESS: STREET 1: 102 WITMER ROAD CITY: HORSHAM STATE: PA ZIP: 19044 FORMER COMPANY: FORMER CONFORMED NAME: NEOSE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZOPF DAVID A MD CENTRAL INDEX KEY: 0001184429 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27718 FILM NUMBER: 05663092 BUSINESS ADDRESS: STREET 1: NEOSE TECHNOLOGIES INC STREET 2: 102 WITMER RD CITY: HORSHAM STATE: PA ZIP: 19044 BUSINESS PHONE: 2153159000 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-03-03 0 0000877902 NEOSE TECHNOLOGIES INC NTEC 0001184429 ZOPF DAVID A MD 102 WITMER ROAD HORSHAM PA 19044 0 1 0 0 Exec. VP and CSO Restricted Stock Unit 0.00 2005-03-03 4 A 0 12715 0.00 A Common Stock 12715 12715 D Restricted Stock Unit 0.00 2005-03-03 4 A 1 9369 0.00 A Common Stock 9369 22084 D The award is a restricted stock unit representing a contractual right to the delivery of the above-specified number of shares of the Company's common stock on a future date. The right to the shares vests, based on the continued service of the grantee, on the first anniversary of the date of grant, subject to acceleration upon a change in control of the Company or involuntary termination not for cause. The actual delivery of the shares will occur upon the earliest of (i) cessation of service, (ii) 18 months following the date of grant, or (iii) a change in control of the Company. The award is a restricted stock unit representing a contractual right to the delivery of the above-specified number of shares of the Company's common stock on a future date. The right to the shares vests, based on the continued service of the grantee, in quarterly installments over the year following the date of grant, subject to acceleration upon a change in control of the Company or involuntary termination not for cause. The actual delivery of the shares will occur upon the earliest of (i) cessation of service, (ii) 18 months following the date of grant, or (iii) a change in control of the Company. David A. Zopf 2005-03-07 -----END PRIVACY-ENHANCED MESSAGE-----